Filing Flows › Sotera Health (SHC) › Guidance & outlook
Sotera Health (SHC) guidance and outlook
Sotera Health (SHC) lowered its guidance on Nov 3, 2026: Revenue +5.25% to +6.75% for FY2026; EBITDA +5.75% to +7.25% for FY2026; Revenue $1.2B for FY2026; Revenue +5.25% to +6.75% for FY2026. Sotera Health's 10-Q filed Nov 3, 2026 makes 10 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | +5.25% to +6.75% | reaffirmed |
| EBITDA | FY2026 | +5.75% to +7.25% | reaffirmed |
| Revenue | FY2026 | +71 bps | new |
| Revenue | FY2026 | $1.2B | lowered |
| Revenue | FY2026 | +5.25% to +6.75% | reaffirmed |
| EBITDA | FY2026 | $632M–$641M | lowered |
| EBITDA | FY2026 | +70 bps | lowered |
| Interest expense | FY2026 | $137M–$140M | reaffirmed |
| Net income | FY2026 | +27% to +28% | reaffirmed |
| EPS | FY2026 | $0.95–$1.01 | reaffirmed |
| Capital expenditures | FY2026 | $200M–$225M | reaffirmed |
From the earnings release filed Nov 3, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 3, 2026
- Management believes Adjusted Net Income and Adjusted EBITDA are useful because they allow management to more effectively evaluate our operating performance and compare the results of our operations from period to period without the impact of certain non-cash items and non-routine items that we do not expect to continue at the same level in the future and other items that are not core to our operations.
- In addition, we believe Adjusted Net Income and Adjusted EBITDA will assist investors in making comparisons to our historical operating results and analyzing the underlying performance of our operations for the periods presented.
- • costs of acquiring and integrating businesses, which will continue to be a part of our growth strategy;
- • share-based compensation expense, which has been, and will continue to be for the foreseeable future, a significant recurring expense and an important part of our compensation strategy.
- In evaluating Adjusted Net Income and Adjusted EBITDA, you should be aware that in the future, we will incur expenses similar to the adjustments in this presentation.
- Our presentations of Adjusted Net Income and Adjusted EBITDA should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non-recurring items.
- We expect that cash on hand, operating cash flows and amounts available under our credit facilities will provide sufficient working capital to operate our business, meet foreseeable liquidity requirements (inclusive of debt service on our long-term debt), make expected capital expenditures including investments in fixed assets to build and/or expand existing facilities, and meet litigation costs that we expect to…
- Our primary long-term liquidity requirements beyond the next 12 months will be to service our debt, make capital expenditures, and fund suitable business acquisitions.
- We expect any excess cash provided by operations will be allocated to fund capital expenditures, potential acquisitions, or for other general corporate purposes.
- Our ability to meet future working capital, capital expenditures and debt service requirements will depend on our future financial performance, which will be affected by a range of macroeconomic, competitive and business factors, including interest rate changes and changes in our industry, many of which are outside of our control.
Sotera Health's latest quarter
Sotera Health, Q3 2026: revenue $325M (+4% year over year), operating margin 25.8%, net earnings $58.4M, operating cash flow $111M. The chart follows the revenue to costs, profit and cash.
Questions
Did Sotera Health raise or lower its guidance?
Sotera Health (SHC) lowered its guidance on Nov 3, 2026: Revenue +5.25% to +6.75% for FY2026; EBITDA +5.75% to +7.25% for FY2026; Revenue $1.2B for FY2026; Revenue +5.25% to +6.75% for FY2026.
What does Sotera Health expect?
Management believes Adjusted Net Income and Adjusted EBITDA are useful because they allow management to more effectively evaluate our operating performance and compare the results of our operations from period to period without the impact of certain non-cash items and non-routine items that we do not expect to continue at the same level in the future and other items that are not core to our operations. In addition, we believe Adjusted Net Income and Adjusted EBITDA will assist investors in making comparisons to our historical operating results and analyzing the underlying performance of our op
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.